This healthcare stock hit a 52-week high today; do you hold it?
This healthcare stock hit a 52-week high today; do you hold it?

This healthcare stock hit a 52-week high today; do you hold it?

Since its Q2FY23 results announcement, the stock has rallied more than 14 per cent in just two trading sessions.

Vishwesh Sanas Article rating: 5.0

Since its Q2FY23 results announcement, the stock has rallied more than 14 per cent in just two trading sessions. 

This pharma company stock went 8 per cent high, do you own it?
This pharma company stock went 8 per cent high, do you own it?

This pharma company stock went 8 per cent high, do you own it?

With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.

Kiran Shroff Article rating: 5.0

This pharma company stock went 8 per cent high, do you own it?                                                                                                                                                                                                       With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.

This low-priced stock hits a fresh 52-week high as it witnessed one of the biggest turnarounds!
This low-priced stock hits a fresh 52-week high as it witnessed one of the biggest turnarounds!

This low-priced stock hits a fresh 52-week high as it witnessed one of the biggest turnarounds!

The stock has skyrocketed by a whopping 368 per cent in the last six months. As a result of this, the stock has turned into a multi-bagger!  

Karan Dsij Article rating: 3.3

The stock reported its Q2FY23 earnings recently while the company is happy to report another profitable quarter in continuation of the first quarter of this FY after reporting losses in the past nine quarters of the previous financial years. Revenue from operations surged to Rs 836 crore, up by nearly 49.55 per cent on a YoY basis

RSS
12

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR